about
Pepsinogen A and C serum levels in relation to acute NSAID-associated mucosal lesions in healthy volunteersSurface immunoglobulin on B lymphocytes as a potential target for specific peptide ligands in chronic lymphocytic leukaemia.Associations of filaggrin gene loss-of-function variants and human papillomavirus-related cancer and pre-cancer in Danish adults.Vitamin D status, filaggrin genotype, and cardiovascular risk factors: a Mendelian randomization approach.No association between loss-of-function mutations in filaggrin and diabetes, cardiovascular disease, and all-cause mortality.Effect of industrially produced trans fat on markers of systemic inflammation: evidence from a randomized trial in women.A possible association between a dysfunctional skin barrier (filaggrin null-mutation status) and diabetes: a cross-sectional study.Seminal progastricsin.Large D-Dimer Fluctuation in Normal Pregnancy: A Longitudinal Cohort Study of 4,117 Samples from 714 Healthy Danish WomenA comparison of anti-nuclear antibody quantification using automated enzyme immunoassays and immunofluorescence assays.Associations of filaggrin gene loss-of-function variants with urinary phthalate metabolites and testicular function in young Danish Men.Glucometabolic hormones and cardiovascular risk markers in antipsychotic-treated patients.Weekday variation in triglyceride concentrations in 1.8 million blood samples.Filaggrin loss-of-function mutations, atopic dermatitis and risk of actinic keratosis: results from two cross-sectional studies.Randomized clinical trial of prevention of seroma formation after mastectomy by local methylprednisolone injection.Filaggrin gene loss-of-function mutations explain discordance of atopic dermatitis within dizygotic twin pairs.Health-related quality of life in adult dermatitis patients stratified by filaggrin genotype.The filaggrin null genotypes R501X and 2282del4 seem not to be associated with psoriasis: results from general population study and meta-analysis.Nickel reactivity and filaggrin null mutations--evaluation of the filaggrin bypass theory in a general population.The association between null mutations in the filaggrin gene and contact sensitization to nickel and other chemicals in the general population.Filaggrin mutations are strongly associated with contact sensitization in individuals with dermatitis.Investigating the causal effect of vitamin D on serum adiponectin using a Mendelian randomization approach.[Retirement of creatinkinase MB].Children with atopic dermatitis and frequent emollient use have increased urinary levels of low-molecular-weight phthalate metabolites and parabens.Filaggrin compound heterozygous patients carry mutations in trans position.Factor V Leiden is associated with increased sperm count.Hand eczema, atopic dermatitis and filaggrin mutations in adult Danes: a registry-based study assessing risk of disability pension.[Amino acids and nomenclature]Error tracking in a clinical biochemistry laboratory.An evaluation of the interference of hydroxycobalamin with chemistry and co-oximetry tests on nine commonly used instruments.Postprandial prolactin suppression appears absent in antipsychotic-treated male patients.Cancer antigen 125 after delivery in women with a normal pregnancy: a prospective cohort study.Carriers of filaggrin gene (FLG) mutations avoid professional exposure to irritants in adulthood.Exposure to phenols, parabens and UV filters: Associations with loss-of-function mutations in the filaggrin gene in men from the general population.n-3 PUFA esterified to glycerol or as ethyl esters reduce non-fasting plasma triacylglycerol in subjects with hypertriglyceridemia: a randomized trial.Laboratory reference intervals during pregnancy, delivery and the early postpartum period.Filaggrin null mutations and association with contact allergy and allergic contact dermatitis: results from a tertiary dermatology clinic.Atopic diseases by filaggrin mutations and birth year.Xerosis is associated with asthma in men independent of atopic dermatitis and filaggrin gene mutations.Gastricsin-mediated proteolytic degradation of human seminal fluid proteins at pH levels found in the human vagina.
P50
Q28260129-A34B2E9A-98F4-4C2D-B12B-30AA7243D7A5Q31038915-2A894CEA-49C4-460E-9AAF-87EB0955C8B8Q33721547-0032F6EF-3AA7-4DEC-9FE7-83238723DFBAQ34608753-A8CC9E1A-040E-4B4D-B05D-85208F30D0D9Q35075742-FEC16DA6-C275-4C71-ADF1-F9F5D87A74A6Q35212902-04BDDFE8-8C5E-4C3D-8AEE-ED84C1A913E5Q35319834-AF1AAB22-C02E-4F79-8495-4C494A4B462CQ36788703-B8524357-50B7-439A-BC54-90C1FC4E78FBQ36854776-648A8288-E7BE-4165-85DD-41F684F3523BQ37588224-1F84D95B-C3BE-4474-9CC8-360BE913B704Q37698783-BAA36E98-EEA6-435D-BC57-9AEFE30697B6Q38422561-AED6684C-2A14-45EB-B070-A14C5E639110Q38734430-3B9850E9-61D4-4BBD-A41A-2A49E78B6765Q38954337-043F1A4B-87C3-4CFE-9EEF-CD6B42210E73Q38984262-BE6918F8-7A7F-4491-A459-2F0E761E2F52Q39366413-F64BF28E-F1FA-4AB2-B545-A7AF64CFAA31Q40416597-5DD58F14-C36B-4BCA-8BEA-5C87ACFAE03DQ42600638-881148C4-1D3D-4BFF-9F00-1A042778626DQ42776497-78934818-571A-4060-89AD-88BCA54F7721Q43117290-A792BFBC-D4C6-46E5-95D8-795BF2A28A1EQ44949952-38D18422-CEB8-428E-9E66-DC8082585C15Q45349309-3A544AD3-4A67-4ACB-899F-4AE9629EFEC4Q46305885-9A0E39DF-3F20-4EEB-AD0C-833F0AA427AAQ47229584-2E2A5F90-A322-4A8E-A96E-E4F2D81B45AFQ47775075-0AEEAF69-7BFB-4C81-9FA3-3C877471F95EQ47777637-98DAEDCD-8F73-4D1E-B6CA-7A0334091CE8Q48254753-C70599A6-2CEA-4711-B7DA-10918F2585E4Q48773974-08BE64A2-3DDA-45B1-98A3-A7649C421805Q48842222-01C63A7C-D86B-4272-A6DA-603F519DBBF3Q50540060-55F17F9D-87BF-42E2-B65F-BA2A98620EB4Q50581819-F88A2FA7-9265-48A1-85D6-0C3F55781101Q50638092-ADCCCF5A-79D4-4AB6-813F-39D72C6FB4AFQ50736596-8C6540FD-0F89-4B35-8F9F-B905519DCA9DQ50992081-600BF34A-759F-4F2B-BAB3-6F27C2DBCF0EQ51312635-5FB9E44F-F94E-4EBD-ADD3-66084BF4B104Q51772919-F64CA662-2DBD-4436-A7B2-CF3041C1C36AQ52602104-341DFF44-1C16-4826-B2C8-0B0D3FC70921Q53652914-A47EA11B-E4DF-45B7-8689-2334596811D4Q54173002-2A9F6512-1C5E-4509-8825-3583BDB7BB13Q54233282-05557DE5-707F-4D81-9819-C64126D932D8
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pal B Szecsi
@nl
Pal B Szecsi
@sl
Pal B. Szecsi
@en
Pal B. Szecsi
@es
type
label
Pal B Szecsi
@nl
Pal B Szecsi
@sl
Pal B. Szecsi
@en
Pal B. Szecsi
@es
prefLabel
Pal B Szecsi
@nl
Pal B Szecsi
@sl
Pal B. Szecsi
@en
Pal B. Szecsi
@es
P106
P108
P1153
36081183200
P31
P496
0000-0003-3446-0411